Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours
Related Biotechnology, Pharmaceutical and Healthcare News
Original Article: Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours
NEXT ARTICLE
More From BioPortfolio on "Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours"